CD79A and nasopharyngeal carcinoma: Pickard et al. employed IgA-VCA, DNase neutralizing activity, and IgA-EBNA1, and showed that seroprevalence in unaffected family members of NPC cases was 5–6 times significantly higher than in members of the community.